MA41643A - BRUTON TYROSINE KINASE INHIBITOR PHARMACEUTICAL FORMULATIONS - Google Patents
BRUTON TYROSINE KINASE INHIBITOR PHARMACEUTICAL FORMULATIONSInfo
- Publication number
- MA41643A MA41643A MA041643A MA41643A MA41643A MA 41643 A MA41643 A MA 41643A MA 041643 A MA041643 A MA 041643A MA 41643 A MA41643 A MA 41643A MA 41643 A MA41643 A MA 41643A
- Authority
- MA
- Morocco
- Prior art keywords
- tyrosine kinase
- kinase inhibitor
- pharmaceutical formulations
- inhibitor pharmaceutical
- bruton tyrosine
- Prior art date
Links
- 229940124291 BTK inhibitor Drugs 0.000 title 1
- 229940125814 BTK kinase inhibitor Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562127717P | 2015-03-03 | 2015-03-03 | |
PCT/US2016/020467 WO2016141068A1 (en) | 2015-03-03 | 2016-03-02 | Pharmaceutical formulations of bruton's tyrosine kinase inhibtor |
Publications (2)
Publication Number | Publication Date |
---|---|
MA41643A true MA41643A (en) | 2018-01-09 |
MA41643B1 MA41643B1 (en) | 2024-02-29 |
Family
ID=59254075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA41643A MA41643B1 (en) | 2015-03-03 | 2016-03-02 | PHARMACEUTICAL FORMULATIONS OF BRUTON'S TYROSINE KINASE INHIBITOR |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR103832A1 (en) |
MA (1) | MA41643B1 (en) |
-
2016
- 2016-03-02 AR ARP160100550A patent/AR103832A1/en unknown
- 2016-03-02 MA MA41643A patent/MA41643B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR103832A1 (en) | 2017-06-07 |
MA41643B1 (en) | 2024-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201907661B (en) | Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor | |
IL255831A (en) | Inhibitors of bruton's tyrosine kinase | |
IL250085A0 (en) | Novel formulations of a bruton's tyrosine kinase inhibitor | |
EP3414234A4 (en) | Bruton's tyrosine kinase inhibitors | |
ZA201805439B (en) | Bruton's tyrosine kinase inhibitors | |
MA41350A (en) | SUMMARY OF A BRUTON TYROSINE KINASE INHIBITOR | |
EP3174539A4 (en) | Inhibitors of bruton's tyrosine kinase | |
EP3141546A4 (en) | Inhibitor of bruton's tyrosine kinase | |
MA50541A (en) | PHARMACEUTICAL FORMULATIONS | |
HK1258699A1 (en) | Dosage form compositions comprising an inhibitor of bruton's tyrosine kinase | |
EP3159340A4 (en) | New bruton's tyrosine kinase inhibitor | |
MA46867A (en) | PHARMACEUTICAL FORMULATIONS | |
ZA201906887B (en) | Bruton's tyrosine kinase inhibitors | |
MA42303A (en) | PHARMACEUTICAL FORMULATIONS | |
ZA201903694B (en) | Inhibitors of bruton's tyrosine kinase | |
MA54716A (en) | REDUCTION OF THE VISCOSITY OF PHARMACEUTICAL FORMULATIONS | |
MA42510A (en) | FORMS AND COMPOSITIONS OF BIARYL INHIBITORS OF BRUTON TYROSINE KINASE | |
MA42509A (en) | ADIPATE FORMS AND COMPOSITIONS OF BRUTON TYROSINE KINASE BIARYL INHIBITORS | |
MA49837A (en) | PHARMACEUTICAL COMPOSITIONS | |
MA55015A (en) | PHARMACEUTICAL FORMULATIONS | |
MA52629A (en) | BRUTON TYROSINE KINASE INHIBITORS | |
MA42546A (en) | BRUTON TYROSINE KINASE INHIBITOR COMBINATIONS AND THEIR USES | |
MA54095A (en) | AQUEOUS PHARMACEUTICAL FORMULATIONS | |
MA46642A (en) | KALLICREIN INHIBITOR MEDICINAL PRODUCTS | |
MA49625A (en) | PHARMACEUTICAL COMPOSITIONS |